Showing results (391-400 of 781) with videos related to

Sort By:
Pageof 79
Nature Methods|April 23, 2005
Activity probe for in vivo profiling of the specificity of proteasome inhibitor bortezomibCelia R Berkers, Martijn Verdoes, Eben Lichtman, et al.
The New England Journal of Medicine|June 12, 2024
Indolent CD4+ CAR T-Cell Lymphoma after Cilta-cel CAR T-Cell TherapyMetin Ozdemirli, Thomas M Loughney, Emre Deniz, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2026
The International Myeloma Society Honors the Life and Legacy of Myeloma Pioneer Brian G. M. Durie, MD, PhD (1942-2025)Philippe Moreau, Shaji Kumar, Noopur S Raje, et al.
Blood|October 1, 2008
Nifuroxazide inhibits survival of multiple myeloma cells by directly inhibiting STAT3Erik A Nelson, Sarah R Walker, Alicia Kepich, et al.
British Journal of Haematology|September 14, 2012
Methyljasmonate displays in vitro and in vivo activity against multiple myeloma cellsSteffen Klippel, Jana Jakubikova, Jake Delmore, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 2012
Pathological crystallization of human immunoglobulinsYing Wang, Aleksey Lomakin, Teru Hideshima, et al.
British Journal of Haematology|May 11, 2016
Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patientsNancy Levin, Andrew Spencer, Simon J Harrison, et al.
Blood|September 20, 2022
A MIR17HG-derived long noncoding RNA provides an essential chromatin scaffold for protein interaction and myeloma growthEugenio Morelli, Mariateresa Fulciniti, Mehmet K Samur, et al.
European Journal of Haematology|May 19, 2020
IgH translocation with undefined partners is associated with superior outcome in multiple myeloma patientsXue-Han Mao, Jun-Ling Zhuang, Duo-Duo Zhao, et al.
Pageof 79